8-K/ALeadership Changes

CADENCE DESIGN SYSTEMS INC 8-K/A Report, Executive Changes (May 12, 2026)

Filed May 12, 2026For Securities:CDNS

Summary

Cadence Design Systems, Inc. (CDNS) has filed an amendment to its previous 8-K filing, providing an update on the committee assignment of Dr. Luc Van den hove. Dr. Van den hove was initially appointed as a director effective January 1, 2026. This amendment clarifies that he has now been designated as a member of the Compensation Committee of the Board, effective May 7, 2026. This update is primarily administrative and does not introduce new financial information or material changes to the company's operational or strategic direction as previously reported. Investors should note that the original filing on November 17, 2025, concerned Dr. Van den hove's directorship, and this 8-K/A solely addresses his committee appointment within the Board of Directors.

Key Highlights

  • 1Cadence Design Systems (CDNS) filed an 8-K/A amendment on May 12, 2026.
  • 2The amendment provides an update on the committee assignment of Dr. Luc Van den hove.
  • 3Dr. Van den hove was appointed as a director effective January 1, 2026.
  • 4The Board has designated Dr. Van den hove as a member of the Compensation Committee.
  • 5This committee assignment is effective as of May 7, 2026.
  • 6The filing does not amend any other information previously reported in the original 8-K filed on November 17, 2025.
  • 7This is an administrative update regarding board composition.

Frequently Asked Questions

The main purpose of this 8-K/A filing is to amend a previous report and specify the committee assignment of Dr. Luc Van den hove, a recently appointed director. He has been designated as a member of the Compensation Committee.

Dr. Luc Van den hove's appointment as a director was effective January 1, 2026. His designation as a member of the Compensation Committee became effective on May 7, 2026.

No, this filing is purely an administrative update regarding the board's committee composition. It does not introduce any new financial information or changes to the company's strategy as previously reported.

This amendment relates to a previous Form 8-K filing made on November 17, 2025, which initially reported the appointment of Dr. Luc Van den hove as a director.